The Expression of Ki-67 and C-erbB-2 in the Sample of Breast Cancer and Its Clinical Significance
Wang Xu-fe
Abstract
Wang Xu-fe
Abstract
Objective:To observe the expression of Ki-67 and C-erbB-2 in the sample of breast cancer and its relationship with the histologic or clinical parameters.Methods:The expression of Ki-67 and C-erbB-2 in 114 cases of the breast carcinomas with the immunohistochemical technique were examined.Analyzed the relationship with Ki-67,C-erbB-2 and the histologic or clinical parameters.Results:The positive rate of Ki-67 was 69.4%(100/144).The expression of Ki-67 was related with the clinical stages of tumor(P=0.000),but not with age,tumor size and lymph node status(P0.05).The positive rate of C-erbB-2 was 52.1%(75/144).The expression of C-erbB-2 was related with the clinical stages of tumor(P=0.003) and lymph node status(P=0.000),but not with age and tumor size(P0.05).In addition,the expression of Ki-76 had a positive correlation with the expressions of C-erbB-2(P=0.001).Conclusion:The expression of Ki-67 and C-erbB-2 is an objective biological marker for estimating the occurrence and progression of breast cancer,which was a guidance for preoperative.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the expression of Ki-67 and C-erbB-2 in the sample of breast cancer and its relationship with the histologic or clinical parameters.Methods:The expression of Ki-67 and C-erbB-2 in 114 cases of the breast carcinomas with the immunohistochemical technique were examined.Analyzed the relationship with Ki-67,C-erbB-2 and the histologic or clinical parameters.Results:The positive rate of Ki-67 was 69.4%(100/144).The expression of Ki-67 was related with the clinical stages of tumor(P=0.000),but not with age,tumor size and lymph node status(P0.05).The positive rate of C-erbB-2 was 52.1%(75/144).The expression of C-erbB-2 was related with the clinical stages of tumor(P=0.003) and lymph node status(P=0.000),but not with age and tumor size(P0.05).In addition,the expression of Ki-76 had a positive correlation with the expressions of C-erbB-2(P=0.001).Conclusion:The expression of Ki-67 and C-erbB-2 is an objective biological marker for estimating the occurrence and progression of breast cancer,which was a guidance for preoperative.
Key concepts: Medicine, Ki-67, Breast cancer, Immunohistochemistry, Lymph node, Clinical significance, Oncology, Pathology